Press Releases about Morphosys Ag ADR
From MorphoSys AG
Via AccessWire
From MorphoSys AG
Via AccessWire
From MorphoSys AG
Via AccessWire
From MorphoSys AG
Via AccessWire
MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
January 18, 2022
From MorphoSys AG
Via AccessWire
From MorphoSys AG
Via AccessWire
From MorphoSys AG
Via AccessWire
MorphoSys AG Reports First Nine Months and Third Quarter 2021 Results
November 11, 2021
From MorphoSys AG
Via AccessWire
Exposures
COVID-19
MorphoSys Announces Departure of Roland Wandeler
November 09, 2021
From MorphoSys AG
Via AccessWire
Exposures
Product Safety
MorphoSys' Licensing Partner Roche Received Breakthrough Therapy Designation for Gantenerumab in Alzheimer's Disease
October 11, 2021
From MorphoSys AG
Via AccessWire
Exposures
Product Safety
From MorphoSys AG
Via AccessWire
From MorphoSys AG
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.